StockWatch
·

BAL PHARMA LTD. Q4 FY26 Results

BALPHARMAQ4 FY26 Results
Filing
MetricValue ( Cr)Q3 FY26Q4 FY25
Revenue84.084.1%2.7%
Total Income83.844.8%1.1%
Expenditure80.626.5%0.3%
PBT3.2279.7%24.1%
Net Profit3.60101.3%33.0%
OPM12.57%1.68pp3.24pp
NPM4.30%2.27pp2.18pp
EPS2.26101.8%33.5%
View full financials

Informational and educational content only. Not investment advice.